We understand that bringing a new drug to market is a lengthy and expensive process. It’s not unusual for a pharmaceutical company to spend a decade and over €500 million in investment to launch a medicinal product. We help clients streamline the process and ultimately achieve faster time-to-market – which is why we’re excited about attending the DIA EuroMeeting.
translate plus help international contract research organisations (CROs) and large pharmaceutical companies such as Astellas Pharma, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co, Merck KGaA, Mundipharma, Novartis and Sauflon gain an even greater competitive edge with our translation support.
DIA will bring together representatives from all areas including healthcare innovators, regulatory professionals, decision makers and service providers, allowing them to discuss this dynamic and highly regulated industry to find the best solutions for their markets.
The event will take place in Paris, France, from Monday 13 to Wednesday 15 April 2015. We’ll be there on Tuesday 14 April and would be happy to advise you on how you can improve your current localisation processes for clinical documentation.